A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

Naitonal Health Insurance Service Ilsan hospital, Ilsan

Hallym University Medical Center, Anyang

Gachon University Gil Mdical Center, Incheon

Local Institution - S09, Incheon

Local Institution - S14, Wŏnju

Wonju Severance Christian Hospital, Wŏnju

Keimyung University Dongsan Hospital, Daegu

Kyungpook National University Hospital, Daegu

Jeonbuk National University Hospital, Jeonju

Local Institution - S10, Jeonju

CHONNAM National University Hwasun Hospital, Hwasun

Local Institution - S02, Seoul

Asan Medical Center, Seoul

Local Institution - S03, Daegu

Local Institution - S07, Daegu

Local Institution - S11, Goyang

Local Institution - S04, Hwasun-gun

Local Institution - S05, Seoul

Local Institution - S06, Seoul

Seoul National University Hospital, Seoul

Local Institution - S08, Seoul

Yonsei University Severance Hospital, Seoul

Local Institution - S12, Seoul

Samsung Medical Center, Seoul

Local Institution - S01, Seoul

The Catholic University, St. Mary's Hospital, Seoul